285 related articles for article (PubMed ID: 8460845)
21. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
[TBL] [Abstract][Full Text] [Related]
22. [Use of peripherally inserted multilumen catheters as an alternative to central venous access].
Pardo De La Vega R; Los Arcos Solas M; Ferrero De La Mano L; Medina Villanueva A; Concha Torre A; Rey Galán C
An Esp Pediatr; 2002 Jul; 57(1):18-21. PubMed ID: 12139888
[TBL] [Abstract][Full Text] [Related]
23. Use of subcutaneous implantable infusion systems in neoplastic and AIDS patients requiring long-term venous access.
Dionigi P; Cebrelli T; Jemos V; Minoli L; Gobbi P; Dimitrov G
Eur J Surg; 1995 Feb; 161(2):137-42. PubMed ID: 7772631
[TBL] [Abstract][Full Text] [Related]
24. Experience with subcutaneous infusion ports in three hundred patients.
Brothers TE; Von Moll LK; Niederhuber JE; Roberts JA; Walker-Andrews S; Ensminger WD
Surg Gynecol Obstet; 1988 Apr; 166(4):295-301. PubMed ID: 3127896
[TBL] [Abstract][Full Text] [Related]
25. [Fully implantable catheter systems. Long-term results--complications].
Wenke K; Markewitz A
Fortschr Med; 1990 May; 108(14):276-9. PubMed ID: 2115492
[TBL] [Abstract][Full Text] [Related]
26. Cathlink 20: a subcutaneous implanted central venous access device used in children with sickle cell disease on long-term erythrocytapheresis--a report of low complication rates.
Raj A; Bertolone S; Bond S; Burnett D; Denker A
Pediatr Blood Cancer; 2005 Jun; 44(7):669-72. PubMed ID: 15700248
[TBL] [Abstract][Full Text] [Related]
27. Permanent central venous access devices.
Wesley JR
Semin Pediatr Surg; 1992 Aug; 1(3):188-201. PubMed ID: 1345487
[TBL] [Abstract][Full Text] [Related]
28. [Experiences with a modified implantation technique of Port-A-Cath systems as continuous venous access in infants and children].
Erhard J; Lange R; Kremens B; Krause U; Eigler FW
Med Klin (Munich); 1991 Oct; 86(10):512-4. PubMed ID: 1758373
[TBL] [Abstract][Full Text] [Related]
29. [Use of central venous catheters implanted subcutaneously in children with neoplasms].
Miniero R; Longo S; Valori A; Ferri M; Vassallo E; Barisone E; Oddenino O; Costamagna G; Miglietta M
Minerva Pediatr; 1989 May; 41(5):277-9. PubMed ID: 2796884
[TBL] [Abstract][Full Text] [Related]
30. Comparison between peripherally implanted ports and externally sited catheters for long-term venous access.
Pullyblank AM; Carey PD; Pearce SZ; Tanner AG; Guillou PJ; Monson JR
Ann R Coll Surg Engl; 1994 Jan; 76(1):33-8. PubMed ID: 8117017
[TBL] [Abstract][Full Text] [Related]
31. [Totally implantable venous access systems. Analysis of complications].
D'Angelo F; Ramacciato G; Caramitti A; Aurello P; Lauro S; Bordin F; Della Casa U
Minerva Chir; 1997; 52(7-8):937-42. PubMed ID: 9411296
[TBL] [Abstract][Full Text] [Related]
32. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
Pittiruti M; Hamilton H; Biffi R; MacFie J; Pertkiewicz M;
Clin Nutr; 2009 Aug; 28(4):365-77. PubMed ID: 19464090
[TBL] [Abstract][Full Text] [Related]
33. Transhepatic central venous catheter for long-term access in paediatric patients.
Mortell A; Said H; Doodnath R; Walsh K; Corbally M
J Pediatr Surg; 2008 Feb; 43(2):344-7. PubMed ID: 18280287
[TBL] [Abstract][Full Text] [Related]
34. [Experience with the use of a subcutaneous venous access system in 57 pediatric patients].
Alliende-González FJ; Antillon-Klüssmann FG; Sierrasesúmaga-Ariznabarreta L; Villa-Elizaga I
Bol Med Hosp Infant Mex; 1990 Aug; 47(8):576-9. PubMed ID: 2257096
[TBL] [Abstract][Full Text] [Related]
35. Peripherally inserted central venous catheters are a good option for prolonged venous access in children with cancer.
Abedin S; Kapoor G
Pediatr Blood Cancer; 2008 Aug; 51(2):251-5. PubMed ID: 18421718
[TBL] [Abstract][Full Text] [Related]
36. The catheter is stuck: complications experienced during removal of a totally implantable venous access device. A single-center study in 200 children.
Wilson GJ; van Noesel MM; Hop WC; van de Ven C
J Pediatr Surg; 2006 Oct; 41(10):1694-8. PubMed ID: 17011271
[TBL] [Abstract][Full Text] [Related]
37. [Central venous catheters with subcutaneous ports for long-term chemotherapy in pediatric oncology].
Zmudzka-Stapińska I; Rawicz M; Sopyło B; Jaranowska D; Rokicka-Milewska R
Acta Haematol Pol; 1992; 23(3):171-8. PubMed ID: 1492541
[TBL] [Abstract][Full Text] [Related]
38. Transhepatic Broviac catheter placement for long-term central venous access in critically ill children with complex congenital heart disease.
Qureshi AM; Rhodes JF; Appachi E; Mumtaz MA; Duncan BW; Asnes J; Radavansky P; Latson LA
Pediatr Crit Care Med; 2007 May; 8(3):248-53. PubMed ID: 17417124
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic therapy. Role of durable venous access.
Rao VK; Charak BS; Giri NK; Banavali SD; Pai SK; Pai VR; Nadkarni KS; Kurkure PA; Saikia TK; Gopal R
J Assoc Physicians India; 1990 Dec; 38(12):897-9. PubMed ID: 2096122
[TBL] [Abstract][Full Text] [Related]
40. [A fully implantable port system for venous access. Personal experience with 91 patients].
Zák P; Tauchman M; Maisnar V; Podzimek K; Mirová S; Voglová J; Dulícek P; Filip S; Chrobák L
Vnitr Lek; 1997 May; 43(5):273-8. PubMed ID: 9601848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
